Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
TMO Transcript
Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
Thermo Fisher Scientific Inc. (TMO) Q3 2025 Earnings Call Transcript
Positive10-22
Thermo Fisher's earnings call highlights strong financial performance, with increased revenue and EPS guidance for 2025 and expected organic growth acceleration in 2026-2027. Strategic M&A, cost management, and improved tariff situations are positive factors. The Q&A session reinforced confidence in growth, despite challenges in China. The overall sentiment is positive due to optimistic guidance and strategic initiatives, suggesting a likely stock price increase in the coming weeks.
Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript
Positive7-23
The earnings call reveals strong financial performance with revenue and margin growth, positive biopharma trends, and strategic deals like the Sanofi acquisition. Despite challenges in China and academic sectors, management's optimism about long-term growth and share gains, alongside effective margin expansion strategies, suggests a positive outlook. The Q&A session reinforced confidence in growth, though some responses lacked detail. Overall, the company's strong position in biopharma and strategic initiatives indicate a likely positive stock price movement.
Thermo Fisher Scientific Inc. (TMO) BofA Securities 2025 Healthcare Conference (Transcript)
Neutral5-13
TMO Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
